Francesco P. Fiorentino
Rome, 00185, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications
METTL1/WDR4 Complex: A Novel Epitranscriptomic Target at the Crossroads of RNA Methylation and Drug Discovery.
Journal: Journal of medicinal chemistry
Published: July 20, 2026
Development of High-Affinity CHD1 Chromodomain Inhibitors.
Journal: Journal of medicinal chemistry
Published: May 05, 2026
Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.
Journal: Journal of medicinal chemistry
Published: April 30, 2026
Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.
Journal: Journal of medicinal chemistry
Published: April 30, 2026
A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.
Journal: Science advances
Published: March 27, 2026
Native Mass Spectrometry of Soluble Proteins with Sodium Chloride Enabled by a Dendritic Detergent.
Journal: ACS measurement science au
Published: February 12, 2026
Quinoline-Based DNA Methyltransferase Inhibitors Featuring Basic Side Chains: Design, Synthesis, and Insight in Biochemical and Anticancer Cell Properties.
Journal: Journal of medicinal chemistry
Published: November 11, 2025
Double Staining Immunohistochemistry and Digital Pathology: Moving Towards Standardization of the Proliferative Index Evaluation in Meningiomas.
Journal: Journal of personalized medicine
Published: November 06, 2025
Sirtuin modulators: a review of patents from 2020 to 2024.
Journal: Expert opinion on therapeutic patents
Published: November 04, 2025
Structural snapshots of Pseudomonas aeruginosa LptB2FG and LptB2FGC reveal insights into lipopolysaccharide recognition and transport.
Journal: Nature communications
Published: July 21, 2025
Last Updated: 09/26/2026